{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:19:59Z","timestamp":1791357599228,"version":"4.3.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.rdc.2017.09.009","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T03:30:40Z","timestamp":1510716640000},"page":"131-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Gastrointestinal and Hepatic Disease in Fibromyalgia"],"prefix":"10.1016","volume":"44","author":[{"given":"Richard A.","family":"Schatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharak","family":"Moshiree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3999(00)00139-2","article-title":"Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls","volume":"49","author":"Malt","year":"2000","journal-title":"J\u00a0Psychosom Res"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2017.09.009_bib2","first-page":"S1","article-title":"An evidence-based position statement on the management of irritable bowel syndrome","volume":"104","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MOG.0b013e3283414065","article-title":"An update on irritable bowel syndrome: from diagnosis to emerging therapies","volume":"27","author":"Chang","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.009_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13053","article-title":"What's new in Rome IV?","volume":"29","author":"Tack","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/17474124.2017.1292130","article-title":"Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?","volume":"11","author":"Whitehead","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2017.09.009_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-012309-103958","article-title":"The brain-gut axis in abdominal pain syndromes","volume":"62","author":"Mayer","year":"2011","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrgastro.2015.121","article-title":"Towards a systems view of IBS","volume":"12","author":"Mayer","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.009_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/gut.2007.119446","article-title":"Guidelines on the irritable bowel syndrome: mechanisms and practical management","volume":"56","author":"Spiller","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1572-0241.2000.01977.x","article-title":"Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia","volume":"95","author":"Sperber","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/BF02064187","article-title":"Functional bowel disorders. A multicenter comparison of health status and development of illness severity index","volume":"40","author":"Drossman","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/30.3.220","article-title":"Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process","volume":"30","author":"Veale","year":"1991","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib13","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1186\/1471-230X-14-182","article-title":"The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli","volume":"14","author":"Tremolaterra","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11916-996-0009-z","article-title":"Fibromyalgia: the gastrointestinal link","volume":"8","author":"Wallace","year":"2004","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","article-title":"Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?","volume":"122","author":"Whitehead","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s003840100299","article-title":"Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder","volume":"16","author":"Lubrano","year":"2001","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1572-0241.2003.07478.x","article-title":"Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia","volume":"98","author":"Chang","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib18","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3748\/wjg.v20.i10.2499","article-title":"Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments","volume":"20","author":"Chang","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00296-014-3109-9","article-title":"An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms","volume":"35","author":"Slim","year":"2015","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2006.12.009","article-title":"Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes","volume":"36","author":"Yunus","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2982.2012.01993.x","article-title":"Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?","volume":"24","author":"Kim","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/AJP.0b013e318032e496","article-title":"Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia","volume":"23","author":"Moshiree","year":"2007","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpsychores.2008.02.021","article-title":"Somatic comorbidities of irritable bowel syndrome: a systematic analysis","volume":"64","author":"Riedl","year":"2008","journal-title":"J\u00a0Psychosom Res"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.009_bib24","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/art.38170","article-title":"Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain","volume":"65","author":"Jensen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","article-title":"The cerebral signature for pain perception and its modulation","volume":"55","author":"Tracey","year":"2007","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/ajg.2011.201","article-title":"Severity in irritable bowel syndrome: a Rome Foundation Working Team report","volume":"106","author":"Drossman","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.009_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2011.08.040","article-title":"Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes","volume":"195","author":"Piche","year":"2011","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2017.09.009_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.009_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/AJP.0b013e318183cfa4","article-title":"The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms","volume":"25","author":"de Souza","year":"2009","journal-title":"Clin J Pain"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2017.09.009_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-3959(99)00215-8","article-title":"Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia","volume":"84","author":"Chang","year":"2000","journal-title":"Pain"},{"issue":"5A","key":"10.1016\/j.rdc.2017.09.009_bib31","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.1016\/S0002-9343(99)00083-2","article-title":"The relationship between psychosocial parameters and outcome in irritable bowel syndrome","volume":"107","author":"Creed","year":"1999","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.009_bib32","first-page":"804","article-title":"The prevalence of fibromyalgia among patients with hepatitis B virus infection","volume":"6","author":"Ozsahin","year":"2013","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.009_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/1756-185X.12593","article-title":"Fibromyalgia incidence among patients with hepatitis B infection","volume":"19","author":"Yazmalar","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00296-003-0290-7","article-title":"Fibromyalgia syndrome in patients with hepatitis C infection","volume":"23","author":"Kozanoglu","year":"2003","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCG.0b013e3182485528","article-title":"Prevalence of fibromyalgia among patients with chronic hepatitis C infection: relationship to viral characteristics and quality of life","volume":"46","author":"Mohammad","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s10620-014-3453-3","article-title":"Fibromyalgia symptoms and cirrhosis","volume":"60","author":"Rogal","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.rhu.0000165291.91623.5c","article-title":"Fibromyalgia frequency in hepatitis B carriers","volume":"11","author":"Adak","year":"2005","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11916-003-0032-2","article-title":"Fibromyalgia, hepatitis C infection, and the cytokine connection","volume":"7","author":"Thompson","year":"2003","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib39","first-page":"1118","article-title":"Lack of association of fibromyalgia with hepatitis C virus infection","volume":"32","author":"Narv\u00e1ez","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10067-007-0737-4","article-title":"Hepatitis C virus infection in Italian patients with fibromyalgia","volume":"27","author":"Palazzi","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","article-title":"Guidelines on the management of fibromyalgia syndrome - a systematic review","volume":"14","author":"Hauser","year":"2010","journal-title":"Eur J Pain"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence-based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10067-015-3144-2","article-title":"A\u00a0meta-analysis to determine the effect of pharmacological and non-pharmacological treatments on fibromyalgia symptoms comprising OMERACT-10 response criteria","volume":"35","author":"Papadopoulou","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"19","key":"10.1016\/j.rdc.2017.09.009_bib44","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","article-title":"Management of fibromyalgia syndrome","volume":"292","author":"Goldenberg","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.009_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.rdc.2009.05.003","article-title":"Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine","volume":"35","author":"Hassett","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010692.pub2","article-title":"Oxycodone for neuropathic pain and fibromyalgia in adults","author":"Gaskell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.rdc.2017.09.009_bib47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3748\/wjg.15.1548","article-title":"Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis","volume":"15","author":"Rahimi","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gtc.2010.12.003","article-title":"Centrally acting therapies for irritable bowel syndrome","volume":"40","author":"Grover","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5009\/gnl.2011.5.3.253","article-title":"Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome","volume":"5","author":"Chey","year":"2011","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","article-title":"A\u00a0randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia","volume":"112","author":"Arnold","year":"2002","journal-title":"Am J Med"},{"issue":"1\u20133","key":"10.1016\/j.rdc.2017.09.009_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2017.09.009_bib52","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.622","article-title":"A\u00a0double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia","volume":"19","author":"Vitton","year":"2004","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib53","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/ar4056","article-title":"A\u00a0randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia","volume":"14","author":"Ohta","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib54","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.009_bib55","first-page":"792","article-title":"A\u00a014-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.009_bib56","article-title":"Pregabalin for pain in fibromyalgia in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","article-title":"Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity","volume":"55","author":"Vaishnavi","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2036.2005.02685.x","article-title":"Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome","volume":"22","author":"Lee","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib59","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rdc.2017.09.009_bib60","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.14309\/00000434-201610001-00521","article-title":"A Placebo-Controlled Trial of Pregabalin for Irritable Bowel Syndrome","volume":"111","author":"Saito","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib61","first-page":"CD010451","article-title":"Probiotics for fibromyalgia","author":"Francis","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.009_bib62","doi-asserted-by":"crossref","first-page":"361s","DOI":"10.1093\/ajcn\/73.2.361s","article-title":"Probiotics, prebiotics, and synbiotics\u2014approaching a definition","volume":"73","author":"Schrezenmeir","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5056\/jnm.2011.17.3.252","article-title":"Irritable bowel syndrome, gut microbiota and probiotics","volume":"17","author":"Lee","year":"2011","journal-title":"J\u00a0Neurogastroenterol Motil"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2017.09.009_bib64","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/MCG.0000000000000420","article-title":"Recommendations for Probiotic use\u20132015 update: proceedings and consensus opinion","volume":"49","author":"Floch","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib65","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.gtc.2007.07.012","article-title":"Bacteria: a new player in gastrointestinal motility disorders\u2013infections, bacterial overgrowth, and probiotics","volume":"36","author":"Quigley","year":"2007","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2008.03750.x","article-title":"Review article: probiotics and prebiotics in irritable bowel syndrome","volume":"28","author":"Spiller","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.rdc.2017.09.009_bib67","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3748\/wjg.14.2650","article-title":"Meta-analysis of probiotics for the treatment of irritable bowel syndrome","volume":"14","author":"McFarland","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.2008.167270","article-title":"The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review","volume":"59","author":"Moayyedi","year":"2010","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.009_bib69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncprheum0245","article-title":"Cognitive behavioral therapy for fibromyalgia","volume":"2","author":"Bennett","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib70","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/ar3496","article-title":"Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial","volume":"13","author":"Alda","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.009_bib71","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3899\/jrheum.100104","article-title":"Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials","volume":"37","author":"Bernardy","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2006.054692","article-title":"Cognitive\u2013behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions","volume":"66","author":"van Koulil","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.009_bib73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pain.2010.06.011","article-title":"Psychological treatments for fibromyalgia: a meta-analysis","volume":"151","author":"Glombiewski","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.rdc.2017.09.009_bib74","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3389\/fpsyg.2015.01658","article-title":"The long-term effectiveness of cognitive behavior therapy for psychosis within a routine psychological therapies service","volume":"6","author":"Peters","year":"2015","journal-title":"Front Psychol"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.009_bib75","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cgh.2015.11.020","article-title":"Short-term and long-term efficacy of psychological therapies\u00a0for irritable bowel syndrome: a systematic review\u00a0and meta-analysis","volume":"14","author":"Laird","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib76","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.13706","article-title":"Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome","volume":"44","author":"Peters","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11916-011-0214-2","article-title":"Exercise therapy for fibromyalgia","volume":"15","author":"Busch","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib78","first-page":"1130","article-title":"Exercise for fibromyalgia: a systematic review","volume":"35","author":"Busch","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.009_bib79","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1055\/s-2008-1038600","article-title":"The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial","volume":"29","author":"Daley","year":"2008","journal-title":"Int J Sports Med"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2010.480","article-title":"Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial","volume":"106","author":"Johannesson","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.009_bib81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13075-015-0789-9","article-title":"Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review","volume":"17","author":"Sanada","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/rheumatology\/keh537","article-title":"Spa treatment for primary fibromyalgia syndrome: a combination of thalassotherapy, exercise and patient education improves symptoms and quality of life","volume":"44","author":"Zijlstra","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.009_bib83","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/09638280400014709","article-title":"Rehabilitation approaches in fibromyalgia","volume":"27","author":"Adams","year":"2005","journal-title":"Disabil Rehabil"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib84","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2013.01.049","article-title":"A\u00a0controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function","volume":"144","author":"Vazquez-Roque","year":"2013","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.009_bib85","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/apt.13167","article-title":"Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome","volume":"41","author":"Rao","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib86","first-page":"605","article-title":"The role of FODMAPs in irritable bowel syndrome","volume":"17","author":"Shepherd","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.009_bib87","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ajg.2016.434","article-title":"A\u00a0randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D","volume":"111","author":"Eswaran","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rdc.2017.09.009_bib88","doi-asserted-by":"crossref","first-page":"962741","DOI":"10.1155\/2013\/962741","article-title":"Efficacy of EMG- and EEG-biofeedback in fibromyalgia syndrome: a meta-analysis and a systematic review of randomized controlled trials","volume":"2013","author":"Glombiewski","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib89","article-title":"Mind and body therapy for fibromyalgia","author":"Theadom","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.009_bib90","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11894-012-0268-2","article-title":"Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome","volume":"14","author":"Asare","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib91","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cgh.2010.02.007","article-title":"Rapid response to cognitive behavior therapy for irritable bowel syndrome","volume":"8","author":"Lackner","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.009_bib92","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12160-014-9665-0","article-title":"Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial","volume":"49","author":"Cash","year":"2015","journal-title":"Ann Behav Med"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.009_bib93","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ajg.2012.66","article-title":"Acupuncture for irritable bowel syndrome: systematic review and meta-analysis","volume":"107","author":"Manheimer","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.009_bib94","article-title":"Acupuncture for treating fibromyalgia","author":"Deare","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.009_bib95","article-title":"Herbal medicines for treatment of irritable bowel syndrome","author":"Liu","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.009_bib96","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-015-3858-7","article-title":"A\u00a0novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms","volume":"61","author":"Cash","year":"2016","journal-title":"Dig Dis Sci"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:15:41Z","timestamp":1760181341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X17300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0889857X17300807"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.009","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal and Hepatic Disease in Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}